DocDollars

Dova Pharmaceuticals

NC · United States · Reporting entity ID 100000316818

Total reported 2019–2025
$4.89M
#714 of 2,960 reporting companies — 0% of all reported industry payments
$2.75M in general payments across 9,672 records, plus $2.14M in research funding across 337 records.

How it breaks down

General payments $2,754,543
Research funding $2,136,592

Where this comes from

Figures are from the CMS Open Payments “payments grouped by reporting entity” dataset, queried live. Reporting entities are applicable manufacturers and group purchasing organisations required to report under the Sunshine Act.

Summary

Dova Pharmaceuticals reported $4.89M to US doctors and teaching hospitals from 2019 to 2025, ranking #714 of 2,960 reporting companies. 44% of that was research funding and 56% general payments such as consulting, speaking, food and travel. 9,672 general payment records and 337 research records were filed.

Common questions about Dova Pharmaceuticals

How much has Dova Pharmaceuticals paid US doctors?

Dova Pharmaceuticals reported $4,891,135 to US physicians and teaching hospitals across the 2019–2025 Open Payments program years: $2,754,543 in general payments, $2,136,592 in research funding.

How does Dova Pharmaceuticals rank among drug and device companies?

It ranks #714 of 2,960 reporting entities by total reported value, about 0% of all industry payments in the dataset.

Does a payment from Dova Pharmaceuticals mean a doctor did something wrong?

No. Open Payments records transfers of value such as speaking fees, consulting, meals, travel and research funding. The data shows the relationship, not its effect on prescribing or care.